These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24698)

  • 1. Monoamine oxidase inhibitory properties of 5-hydroxymethyl-3-m-tolyloxazolidin-2-one (toloxatone).
    Kan JP; Malone A; Benedetti MS
    J Pharm Pharmacol; 1978 Mar; 30(3):190-2. PubMed ID: 24698
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
    Benedetti MS; Boucher T; Carlsson A; Fowler CJ
    Biochem Pharmacol; 1983 Jan; 32(1):47-52. PubMed ID: 6830619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat.
    Keane PE; Kan JP; Sontag N; Benedetti MS
    J Pharm Pharmacol; 1979 Nov; 31(11):752-4. PubMed ID: 41906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase.
    Fowler CJ; Strolin Benedetti M
    J Neurochem; 1983 Feb; 40(2):510-3. PubMed ID: 6822834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of beef plasma amine oxidase by clorgyline.
    Houslay MD; Tipton KF
    Biochem Pharmacol; 1975 Feb; 24(3):429-31. PubMed ID: 1125055
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H; Wakui Y; Arai Y; Kamijo K
    Biochem Pharmacol; 1980 Oct; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the rat.
    Strolin Benedetti M; Dow J; Boucher T; Dostert P
    J Pharm Pharmacol; 1983 Dec; 35(12):837-40. PubMed ID: 6141254
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of semicarbazide-sensitive amine oxidase by monoamine oxidase B inhibitors from the oxazolidinone series.
    Dostert P; Guffroy C; Strolin Benedetti M; Boucher T
    J Pharm Pharmacol; 1984 Nov; 36(11):782-5. PubMed ID: 6150988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism between long acting monoamine oxidase inhibitors (MAOI) and MD780515, a new specific and reversible MAOI.
    Kan JP; Benedetti MS
    Life Sci; 1980 Jun; 26(25):2165-71. PubMed ID: 7401915
    [No Abstract]   [Full Text] [Related]  

  • 15. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
    Shekhar C; Mayanil K; Baquer NZ
    Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase by d-methamphetamine.
    Suzuki O; Hattori H; Asano M; Oya M; Katsumata Y
    Biochem Pharmacol; 1980 Jul; 29(14):2071-3. PubMed ID: 6773528
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of monoamine oxidation in subfractions of crude mitochondria of rat brain by clorgyline and Lilly 51641.
    Mitra C; Guha SR
    Biochem Pharmacol; 1978; 27(20):2455-7. PubMed ID: 728196
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats.
    Finberg JP; Tal A
    Br J Pharmacol; 1985 Mar; 84(3):609-17. PubMed ID: 2985158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo.
    Green AL; El Hait MA
    J Pharm Pharmacol; 1980 Apr; 32(4):262-6. PubMed ID: 6103055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.